DeviceTalks Podcast Network

DeviceTalks Podcast Network

By DeviceTalks Podcast NetworkNewsHealth & FitnessTechnologyTech News
Download on the App Store

All DeviceTalks Podcast Network episodes

  • Abbott’s Fishler on Dual Chamber Leadless Pacemaker from “submarine” tests to FDA approval
    In this episode of AbbottTalks, Matthew Fishler, PhD, Chief Engineer & Senior Director, Product Development, Cardiac Rhythm Management at Abbott Cardiovascular, shares his experience helping to develop the revolutionary dual-chamber leadless pacemaker system, taking us through the significant challenges and triumphs of creating a device that ensures precise coordination between the heart’s atrial and ventricular chambers without traditional leads.
    Fishler recounts the meticulous development process, from initial concept testing using rudimentary "submarines" in saline tanks to achieving FDA approval. He highlights the deliberate approach taken to ensure safety and effectiveness, resulting in a device that now benefits patients with more comprehensive cardiac support. Lastly, he explains the innovative i2i communication technology, which uses electrical impulses to enable seamless device interaction, a concept likened to a “moonshot” due to its unprecedented nature.
    Thank you to ProMed for sponsoring this episode of AbbottTalks. To learn more about ProMed’s prototype services, visit: https://promedmolding.com/capabilities/prototyping/
    Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.
    42 min
  • CEO Rowland shares how Endotronix will bring hope to heart patients following FDA Cordella approval
    In this week’s DeviceTalks Weekly Podcast, Host Tom Salemi talks with Endotronix CEO Harry Rowland about the company’s long road to securing PMA approval from the FDA for its Cordella Pulmonary Artery (PA) Sensor System for the treatment of heart failure patients.
    But first we welcome back the Newmarker’s Newsmakers! MassDevice Editor-in-Chief Chris Newmarker highlights news from Masimo, Stryker, Medtronic, ICU Medical and Edwards Lifescience.
    This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com.
    Thank you for listening to the DeviceTalks Weekly podcast.
    Subscribe now to the DeviceTalks Podcast Network.
    1 hr 1 min
  • Stryker’s Pierce updates on Vocera, 1788, Neuro, & interest in soft-tissue surgical robotics system
    In this episode of StrykerTalks, we welcome back Andy Pierce, Group President of MedSurg and Neurotechnology, to discuss the impact of the Vocera acquisition and how Vocera's dynamic clinical workflow addresses staffing shortages and enhances efficiency.
    Additionally, the episode covers Stryker's new LIFEPAK 35 monitor/defibrillator, advancements in the 1788 visualization platform, and ongoing innovations in the neurovascular space. Pierce also touches on plans for incorporating Vocera into more Stryker products and the company's interest in soft-tissue surgical robotics.
    Want more from Andy Pierce? Explore his previous appearances on the DeviceTalks Podcast Network.
    Prior appearance on StrykerTalks:
    https://www.devicetalks.com/pierce-talks-innovation-vocera-ascs-and-why-nurses-hug-strykers-neptune-waste-management-system/
    Prior appearance on DT Weekly:
    https://www.devicetalks.com/lobo-and-pierce-talk-wright-cool-tech-robotics-and-the-not-so-secret-plans-to-keep-stryker-growing/
    Thank you to S2 Insight, Inc. for sponsoring this episode. To learn more about how S2 Insight, Inc. supports medical device companies, visit https://www.s2insight.com/case-studies.
    Thank you for listening to the StrykerTalks Podcast.
    Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
    34 min
  • CEO Powell explains how RefleXion developed precise targeting system for cancer-killing radiotherapy
    In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Powell, CEO and president of RefleXion, maker of a smart radiotherapy system used to combat cancer. Powell talks about his path into MedTech and how the company’s ScinTix system can “debulk” widespread cancer in patients.
    This episode is sponsored by the DeviceTalks West conference taking place Oct. 16-17 at the Santa Clara Convention Center. Register at West.DeviceTalks.com
    Thank you for listening to the DeviceTalks Weekly Podcast.
    Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
    55 min
  • Hologic's FDA-cleared Genius Digital Dx Systems leads AI innovation in cervical cancer prevention
    In this episode of DeviceTalks AI, we explore the advancements in AI-driven technologies in women's health and cancer diagnostics.
    In our keynote interview, we speak with Michael Quick, Vice President of R&D and Innovation in Cytology & Oncology at Hologic. Quick shares his journey from a pre-med student to a leader in cytology innovation. He discusses the development and impact of Hologic’s Genius Digital Diagnostic Systems, the first FDA-approved digital cytology system, which leverages AI to enhance cervical cancer screening accuracy and efficiency. Michael emphasizes Hologic’s dedication to women's health and the critical role of AI in addressing the shortage of skilled cytologists, ensuring faster and more accurate diagnostics for patients worldwide. He also touches on the challenges and opportunities faced during the FDA approval process and the importance of early and collaborative engagement with regulatory bodies.
    We also hear from Dr. Wael Yared, Chief Technology Officer at Tecan, who highlights Tecan's contributions to cancer research and diagnostics. Dr. Yared elaborates on the company's innovations in liquid biopsy and solid tissue biopsy workflows, which leverage AI to streamline processes and reduce errors. He emphasizes the significance of partnerships in driving medical advancements and the role of AI in personalized medicine and multiomic capabilities.
    This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about Tecan visit, https://partnering.tecan.com
    Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode.
    Thank you for listening to DeviceTalks AI!
    58 min
  • Mullings and Bell unpack SRS 2024: Surprises, disappointments and where is surgical robotics headed?
    In this episode of Device Talks Weekly Podcast, Host Tom Salemi breaks down the recent Society of Robotic Surgery annual meeting with industry experts Steve Bell and Joe Mullings of The Mullings Group. The discussion ranges beyond the meeting into the state of Surgical Robotics.
    This episode is sponsored by DeviceTalks West. Go to West.DeviceTalks.com for more information.
    Thanks for listening to this episode of the DeviceTalks Weekly Podcast.
    Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
    1 hr 14 min
  • Boston Scientific Interventional CMO talks CAD, stents, drug-coated balloons and the lure of history
    In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi speaks with Dr. Janar Sathananthan, chief medical officer of Boston Scientific’s interventional cardiology therapies business about the coronary artery disease, stenting and its AGENT drug-coated balloon.
    This episode is sponsored by Freudenberg Medical. For more information, please visit www.freudenbergmedical.com.
    MassDevice’s Chris Newmarker and Sean Whooley join the Newmarker’s Newsmakers section to talk about the big MedTech story of the week as well as the news coming out of the American Diabetes Association annual meeting.
    Salemi also shares some thoughts from the Annual Meeting of the Society of Robotic Surgery.
    Thank you for listening to the DeviceTalks Weekly Podcast.
    Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.
    1 hr 10 min
  • CEO Chaplin explains how Kardium packed the power of the globe into its PFA cardiac ablation device
    In this episode of the DeviceTalks Weekly podcast, Kevin Chaplin, CEO of Kardium, a Vancouver-based electrophysiology device company, shares details of the company’s Globe® Pulsed Field Mapping and Ablation System. With $100 million in new capital, the company is poised to open a new front in the pulsed-field ablation battle.
    Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information.
    Thank you for listening to the DeviceTalks Weekly Podcast.
    Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.
    49 min
  • Asensus Surgical on reshaping robotic surgery with augmented intelligence; AWS's purpose-built AI
    In the latest episode of DeviceTalks AI, President and CEO of Asensus Surgical, Anthony Fernando walks us through the significant differences between augmented intelligence and artificial intelligence and how Asensus is leveraging these technologies to improve surgical outcomes. Anthony discusses the inception and evolution of Asensus Surgical's innovative robotic platforms, including the Senhance and Luna systems, and delves into the core advantages of using augmented over artificial intelligence to aid surgeons. He describes the Intelligent Surgical Unit (ISU), its unique regulatory pathway, and its pivotal role in providing the surgeon with real-time context, ensuring higher precision, consistency, and reduced cognitive fatigue during surgeries.
    To get the full story on the Karl Storz acquisition of Asensus Surgical, visit: https://www.massdevice.com/asensus-to-be-acquired-karl-storz/
    In the second part of the episode, GM of Health AI at Amazon Web Services (AWS), Tehsin Syed, talks about the intersection of healthcare, life sciences, and AI and how AWS is helping healthcare and life sciences organizations leverage AI without the need for extensive technical expertise. Tehsin highlights AWS services like Comprehend Medical and HealthScribe, which are designed to simplify the processing and analysis of healthcare data. He also discusses the potential of generative AI in accelerating drug discovery, clinical trial optimization, and personalized medicine.
    Make sure to check out DeviceTalks Spotlight, a growing library of insights and expertise from the best in the medical device business: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4598161/devicetalks-spotlight
    Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode.
    Thank you for listening to DeviceTalks AI!
    1 hr 18 min
  • OIV’s Hunter-Syed on corporate venture capital’s growing influence; Bell previews SRS annual meeting
    In this week’s DeviceTalks Weekly Podcast, we dig deeper into the worlds of Corporate Venture Capital and Surgical Robotics.
    In our keynote interviews, Host Tom Salemi speaks with Abby Hunter-Syed, director of Olympus Innovation Ventures (OIV), the corporate arm of Olympus, the medical giant. Hunter-Syed explains how her own entrepreneurial experience led her to discover the joy of supporting start-ups. In this interview she explains why she favors open communication and how entrepreneurs can best approach OIV for capital.
    Before that conversation, we visit with Surgical Robotics Expert Steve Bell, an MedTech veteran who now advised start-ups. We preview the upcoming annual meeting of the Society of Surgical Robotics, which promises to unveil many interesting new surgical robotics systems. You can find out more about Steve Bell at www.howtostartupinmedtech.com.
    This episode is sponsored by DeviceTalks West. Registration opens next week.
    Thanks for listening to this episode of the DeviceTalks Weekly Podcast.
    Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
    48 min